Contrast Media Injector Market Overview and Introduction

Contrast media injectors are used to inject contrast agents or contrast media into the body to enhance the blood and perfusion in tissues for a medical imaging procedure. These contrasting substances help in readily distinguish one set of tissue from another. Contrast media injectors are available in mobile or stationary configurations. The mobile version is mounted to a wheeled pedestal whereas the other version is mounted to a rack or shelf in patient room or control room. Intravascular contrast media is used in a wide array applications including diagnostic and interventional procedures by, magnetic resonance imaging, computed tomography and angiography.

The major factors driving contrast media injectors market include increasing burden of chronic & infectious diseases, increasing use of computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures and rising demand for early diagnosis. Moreover, wide range of clinical application and rising investments and government funds are fueling the market. However, high cost of contrast media injector and the dearth of skilled professionals are some of the factors that might hinder the growth of the market to a certain extent.

The global contrast media injectors market is segmented by product, application, end user and region.

Contrast Media Injector By Product

On the basis of product, the contrast media injectors market is segmented into consumables, injector system and accessories. The consumable segment is again bifurcated into injector heads and syringes, tubes and other consumables. Similarly, injector system is bifurcated into CT injectors, MRI injector and angiography injector. The consumables segment is anticipated to witness highest CAGR during the forecast period. The share of this segment can be attributed to growing need of consumables to maintain safety and hygienic conditions during diagnostic and interventional procedures.

Contrast Media Injector By Application

Based on application market can be segmented into radiology, interventional cardiology and interventional radiology. Radiology segment held the largest share of the contrast media injectors market. This largest share can be attributed to increasing use of contrasting agent for carrying out radiological procedures.

Contrast Media Injector By End User

Based on the end users, the market is segmented into hospitals and diagnostic imaging centers. The hospitals segment held the largest market share owing to factors such as rising number of diagnostic imaging procedures performed in hospitals as well as rising demand & adoption of minimally invasive procedures by patients in the hospitals

Contrast Media Injector Market By Region

The global contrast media injectors market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of contrast media injectors, followed by Europe and Asia Pacific. North America will continue to dominate the global contrast media injectors market in the forecast period owing to factors such as increasing disease burden, growing geriatric population and increasing research activities in this region.  However, Asia Pacific is expected to witness the highest CAGR during the forecast period owing to factors such as rising aging population, rising incidences of cancer and increasing government imitative for research activities and for the modernization of healthcare.

Contrast Media Injector Market Prominent Players

Some of the prominent players in the global contrast media injectors market include Bayer AG, Bracco, Guerbet Group, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo Co., Ltd., Takasago Electric, Inc., Shenzhen Seacrown Electromechanical Co,. Ltd., ulrich GmbH & Co. KG, MEDTRON AG and APOLLO RT Co. Ltd., among others.